Skip to main content
Clinical Trials/NCT02294318
NCT02294318CompletedNot Applicable

HealthCall: Brief Intervention to Reduce Drug Use in HIV Primary Care

Research Foundation for Mental Hygiene, Inc.1 site in 1 country47 target enrollmentStarted: June 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
47
Locations
1
Primary Endpoint
Mean Number of Days Used Primary Drug (NumDU)

Study Overview

Brief Summary

This pilot study goal is to compare two different treatments to help HIV positive patients reduce their concurrent drinking and non-injection drug use.

Detailed Description

The goal of this study is to compare the effects of brief motivational interviewing with participation in HealthCall to brief motivational interviewing alone on non-injection drug and alcohol use. HealthCall involves 2-3 minutes of daily smartphone use to track drug use, drinking behaviors and other aspects of health, followed by personalized feedback in a graph after 30 and 60 days of using the smartphone.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age 18 and older;
  • •During the prior 30 days, > 4 days of non-injection of cocaine, methamphetamine or heroin, one of which is identified by the patient as his/her primary drug During prior 30 days, > 1 day of binge drinking (>4 drinks on one occasion); Completion of medically supervised detoxification if such detoxification is required; HIV Positive ; Able to give informed consent

Exclusion Criteria

  • •Patient is currently psychotic, suicidal, or homicidal. Patient has injected any drug in the last 6 months Patient has definite plans to leave the greater New York metropolitan area within the study period.
  • •Patient has gross cognitive/psychomotor impairment as evidenced on the Halstead-Reitan Trails (A+B) Patient does not speak English or Spanish Patient has a hearing and/or vision impairment that precludes smartphone use.

Arms & Interventions

Motivational Interviewing (MI)

Active Comparator

Participants will engage in a 30-minute Motivational Interviewing session with the study counselor to discuss participant's drug and alcohol use, its implications for their health, and the possibility of drug and alcohol use reduction. This counseling session is intended to help people reduce their drug and alcohol use if they wish. In the counseling session, participants describe the pros and cons of their drug and alcohol use and whether it might be important to quit using drugs and drinking alcohol. Open discussion of the pros (what they like about drug use and drinking) and cons (what they don't like) can help people think about reducing drug and alcohol use in a more complete way than they might have before. This arm will be compared to the HealthCall+Motivational Interviewing arm.

Intervention: Motivational Interviewing (Behavioral)

HealthCall+Motivational Interviewing

Experimental

The HealthCall+Motivational Interviewing arm will investigate whether the addition of HealthCall, a smartphone application designed to keep track of the participant's drug and alcohol use and other health-related behaviors through short daily use, will help participants reduce their substance use more than Motivational Interviewing alone. Participants will receive the same 30-minute Motivational Interviewing session as described in the MI arm. After the session, participants will be introduced to HealthCall and will be asked to use the app daily over the next 30 days. Each use lasts 2-3 minutes and can be done anywhere on the phone in the U.S. The purpose of daily HealthCall use is to help participants keep track of their drug and alcohol use.

Intervention: HealthCall+Motivational Interviewing (Behavioral)

Outcomes

Primary Outcomes

Mean Number of Days Used Primary Drug (NumDU)

Time Frame: 60 days

This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).

Mean Dollar Amount Spent Per Day on Primary Drug (QuantU)

Time Frame: 60 days

This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).

Mean Number of Drinking Days (NumDD)

Time Frame: 60 days

This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).

Mean Number of Drinks Per Day (QuantDD)

Time Frame: 60 days

This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Efrat Aharonovich

Research Scientist V

Research Foundation for Mental Hygiene, Inc.

Study Sites (1)

Loading locations...

Similar Trials